Dr. John L. Lyszczarz Iii, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Psc 819 Box 1829, Fpo, AE 09645 Phone: 011-349-56823408 |
Dr. Bryn Joi Haase Reina, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Psc 836, Box 0374, Fpo, AE 09636 Phone: 390-955-64840 Fax: 390-955-64864 |
Dr. Glen Collier Crawford, M.D. Psychiatry & Neurology - Forensic Psychiatry Medicare: Not Enrolled in Medicare Practice Location: Psc 827 Box 1000, Fpo, AE 09617 Phone: 202-468-2821 |
News Archive
A phase I clinical trial showed diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy can be reprogrammed to respond to treatment using the drug azacitidine, according to a study published in Cancer Discovery, a journal of the American Association for Cancer Research.
The National Viral Hepatitis Roundtable (NVHR) is hosting a briefing, "The Experts' Perspective: Gaps and Strategies in the Hepatitis Crisis." "Leading hepatitis physicians, one of whom is a Congressman, will be on the hill today to educate Congress on the importance of developing a strategy to reduce the significant morbidity and mortality from end-stage liver disease and liver cancer caused by chronic hepatitis B and chronic hepatitis C in the United States," said Martha Saly, Director of NVHR.
A new psychotherapeutic ingredient, emotion regulation skills training, has been found to enhance standard cognitive behavior therapy for depression in a trial published in the current issue of Psychotherapy and Psychosomatics.
New research focusing on high-frequency oscillations, termed ripples and fast ripples, recorded by intracranial electroencephalography, may provide an important marker for the localization of the brain region responsible for seizure activity.
Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of biologic therapeutics, announced today that it recently secured an $8.5M series C financing led by Excel Venture Management. Santé Ventures, an existing investor, also participated in the round.
› Verified 3 days ago